Insider Trading May 28, 2026 06:03 PM

Director's Stake Increase at Jack In The Box Amid Mixed Quarterly Results

Guillermo Diaz Jr.'s recent purchase of company stock occurs as analysts adjust price targets following a decline in same-store sales.

By Jordan Park JACK

A director at Jack in the Box Inc. recently acquired shares, signaling continued interest despite broader market pressures and mixed operational results reported by the company. The acquisition comes against a backdrop where financial analysts have issued multiple downgrades and reduced price targets due to concerns over sales performance and the balance sheet.

Director's Stake Increase at Jack In The Box Amid Mixed Quarterly Results
JACK

Key Points

  • The director's stock purchase suggests internal confidence despite market declines.
  • Mixed Q2 results show strong EBITDA but weak same-store sales performance.
  • Analyst downgrades reflect concerns over the balance sheet and declining core sales.

Guillermo Diaz Jr., who serves as a director at Jack in the Box Inc. (NASDAQ:JACK), recently increased his personal stake in the company's common stock through an acquisition that occurred on May 28, 2026. The total value of this transaction amounted to $68,622.

Specifically, Mr. Diaz Jr. purchased 5,962 shares at a unit price of $11.51 per share. This purchase represents an addition to his existing direct holdings in the fast-food restaurant chain. Notably, this acquisition takes place while the stock has seen a decline of 41% over the past six months, trading near $11.56, which is quite close to the price point at which the director executed the buy.

Following the reported transaction, Mr. Diaz Jr.'s direct ownership of Jack in the Box common stock totals 20,692 shares. From a valuation standpoint, InvestingPro currently indicates that the stock trades near its Fair Value. Analysts have provided price targets ranging from $12 to $28 for JACK.


Operational Challenges and Analyst Reactions

The recent activity in the stock and among company leadership is framed by a complex set of operational results and subsequent adjustments from major financial institutions. During its second-quarter earnings report, Jack In The Box reported an EBITDA of $51.3 million. This figure slightly surpassed the consensus estimate provided by analysts, which was $50.7 million.

However, this positive bottom-line indicator was offset by challenges related to same-store sales. Same-store sales declined by 3.8%, missing the expected decline rate of 2.4%. This performance gap prompted several large investment banks to adjust their outlook and pricing for the company.

Analyst Adjustments and Concerns

Following the earnings release, major financial players issued mixed assessments. Guggenheim downgraded Jack In The Box from a Buy rating to Neutral, pointing specifically to concerns regarding the balance sheet structure. This concern highlights that the company maintains $230 million of equity against a total debt burden of $1.6 billion.

Similarly, Jefferies reduced its price target for the company down to $12.50 from an initial assessment of $20.00. While maintaining a Hold rating, Jefferies's adjustment was directly attributed to the sales miss reported by the firm.

UBS lowered its suggested price target to $14 from a previous level of $23. This reduction reflected both weaker-than-expected same-store sales and an increased focus on

Risks

  • Sustained weakness in same-store sales could undermine overall growth trajectory, impacting consumer spending confidence.
  • The existing balance sheet structure, with $230 million of equity against $1.6 billion in debt, presents a significant financial risk requiring careful management.
  • Continued market uncertainty and the necessity for substantial initiatives like 'Jack on Track' to boost performance indicate operational volatility.

More from Insider Trading

Aveanna Healthcare 10% Owner Vigano Sells $43.68m in Shares Jun 5, 2026 Robert M. Williams Jr. Divests $43.68 Million in Aveanna Healthcare Holdings Stock Jun 5, 2026 J.H. Whitney Equity Partners VII Sells $36.4M Stake in Aveanna Healthcare Jun 5, 2026 NHI CEO D. Eric Mendelsohn Buys $103,260 in Company Stock Jun 5, 2026 Provident Financial Holdings Executive Sells Shares Amid Earnings Miss Jun 5, 2026